Voyager Therapeutics, Inc.

Historical 13F Holders

Symbol
VYGR
CUSIP
92915B106
All holders as of
Q2 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q2 115 33.2 M $103 M
2025 Q1 119 34.7 M $117 M
2024 Q4 136 34.6 M $196 M
2024 Q3 134 35.4 M $207 M
2024 Q2 134 38.9 M $308 M
2024 Q1 141 36.5 M $340 M
2023 Q4 116 27.8 M $235 M
2023 Q3 118 27.3 M $211 M
2023 Q2 111 26.9 M $308 M
2023 Q1 90 23.8 M $184 M
2022 Q4 75 24.1 M $147 M
2022 Q3 75 24.1 M $143 M
2022 Q2 83 24.1 M $142 M
2022 Q1 79 22.5 M $171 M
2021 Q4 68 18.9 M $51.4 M
2021 Q3 73 22.2 M $58.6 M
2021 Q2 84 23.4 M $96.8 M
2021 Q1 108 26.9 M $130 M
2020 Q4 110 27.8 M $199 M
2020 Q3 117 28.2 M $301 M
2020 Q2 120 30.1 M $380 M
2020 Q1 127 30.3 M $277 M
2019 Q4 146 31.3 M $436 M
2019 Q3 138 31.8 M $559 M
2019 Q2 139 29.3 M $797 M
2019 Q1 116 27.5 M $526 M
2018 Q4 120 28.1 M $265 M
2018 Q3 128 29.2 M $552 M
2018 Q2 130 29.1 M $569 M
2018 Q1 113 27.3 M $512 M
2017 Q4 102 25.2 M $418 M
2017 Q3 79 11.3 M $233 M
2017 Q2 52 10.9 M $98.1 M
2017 Q1 49 11.1 M $147 M
2016 Q4 59 12.5 M $160 M
2016 Q3 52 10.6 M $128 M
2016 Q2 48 10.6 M $116 M
2016 Q1 43 10.0 M $87.0 M
2015 Q4 36 10.4 M $225 M